First in vivo paper from HaemO2 mutations!

A new paper in Free Radicals in Biology and Medicine features the use of PEGylated versions of HaemO2 in a  mouse model. The research shows that HaemO2 mutants protect the functional form of haemoglobin and last longer in vivo

The article is free to view or download here:

https://www.sciencedirect.com/science/article/pii/S0891584918312978

Haem O2 European patent granted!

You can read all the details at:

https://register.epo.org/application?number=EP08775775&lng=en&tab=main

HaemO2 research hits journal front cover

The prestigious Biochemical Journal featured the novel HaemO2 mutation on its front cover

The cover can be seen here:

http://www.biochemj.org/content/473/19.cover-expansion

And the article is free to view or download here:


http://www.biochemj.org/content/473/19/3371

HaemO2 selected as semi-finalists in the Universal Biotech Innovation prize.

Our project was selected as semi-finalists for the Universal Biotech Innovation Prize: https://www.universal-biotech-prize.com

HaemO2 inventor short-listed for Innovation Award

Professor Chris Cooper has been shortlisted for the award of "Most Promising Innovator" at the BBSRC 2015 Innovator of the Year Awards. Click here for details.

HaemO2 spin out company formed

January 2015
University of Essex forms a spin out company - CymBlood - to develop the HaemO2 project using adult haemoglobin to create an artificial blood substitute

OBN Annual Awards: HaemO2 Shortlisted

OBN have announced the nominations for their prestigious Annual Awards. Presented on the Thursday 2 October 2014, in Oxford’s historic Ashmolean Museum, they will applaud the cream of UK bioscience, diagnostics and medtech companies. Eleven awards are up for grabs, and HaemO2 have been nominated for 'Best New Medtech Development Programme.'

http://www.haemo2.com/news.html